The kinetics of inhibition of thrombin by antithrombin in the presence of components of the hemostatic system.

The inhibition of human thrombin by antithrombin has been measured in pure systems in the presence of other components of the hemostatic system that might affect the kinetics of the reaction. These included fibrinogen, calcium ions, phospholipid, prothrombin, platelets (both adenosine diphosphate [ADP]-stimulated and -unstimulated), and platelet extracts. Inhibition rates were measured in each case by a discontinuous amidolytic assay over a range of antithrombin concentrations, from 0 to 4.5 mumol/L. Under all conditions, rates of inhibition were proportional to antithrombin concentration. Calcium ions at 5 mmol/L caused a small (20%) reduction in rate, but phospholipid and prothrombin had no additional effect. In contrast, both fibrinogen and platelets significantly changed the rate of inhibition. In the presence of calcium, fibrinogen at concentrations from 0 to 12 mumol/L reduced the rate of inhibition in a competitive manner, giving an apparent Kd for fibrinogen of 6.0 mumol/L. As the plasma fibrinogen level is about 8 mumol/L, one may therefore predict that variations in fibrinogen level will have a significant effect on the rate of thrombin inhibition in plasma. More unexpected was the observation that platelets increase the rate of inhibition: unstimulated platelets increased the rate constant by 40%, and ADP-stimulated platelets increased it by 55%. However, this acceleratory effect could not be mimicked with either a KCI extract or a Triton extract of platelets, and its cause remains unknown. In sum, it has been shown that the rate of inhibition of thrombin can be modulated in at least three ways-antithrombin concentration, fibrinogen concentration, and platelets; each of which can vary independently in vivo. It is well known that defects of the first lead to an increased risk of thrombosis, and it is proposed that this may be substantially caused by changes in the kinetics of inhibition such as those described. Additionally, it is suggested that changes in inhibition rate caused by other components may also be significant, for the same reason, in modulating the clotting system in vivo.

[1]  J. Marcum,et al.  Acceleration of thrombin-antithrombin complex formation in rat hindquarters via heparinlike molecules bound to the endothelium. , 1984, The Journal of clinical investigation.

[2]  M. Nesheim.  A simple rate law that describes the kinetics of the heparin-catalyzed reaction between antithrombin III and thrombin. , 1983, The Journal of biological chemistry.

[3]  J. McDonagh,et al.  Studies on the mechanism of thrombin. Interaction with fibrin. , 1983, The Journal of biological chemistry.

[4]  M. Griffith.  Heparin-catalyzed inhibitor/protease reactions: kinetic evidence for a common mechanism of action of heparin. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[5]  J. Shafer,et al.  Steady state kinetic parameters for the thrombin-catalyzed conversion of human fibrinogen to fibrin. , 1983, The Journal of biological chemistry.

[6]  D. Tollefsen,et al.  Heparin cofactor II. Purification and properties of a heparin-dependent inhibitor of thrombin in human plasma. , 1982, The Journal of biological chemistry.

[7]  C. Esmon,et al.  Functional properties of an endothelial cell cofactor for thrombin-catalyzed activation of protein C. , 1981, The Journal of biological chemistry.

[8]  C. Esmon,et al.  Identification of an endothelial cell cofactor for thrombin-catalyzed activation of protein C. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[9]  T. Detwiler,et al.  Platelet thrombin receptors. Binding of alpha-thrombin is coupled to signal generation by a chymotrypsin-sensitive mechanism. , 1980, The Journal of biological chemistry.

[10]  J. Jesty.  The kinetics of formation and dissociation of the bovine thrombin.antithrombin III complex. , 1979, The Journal of biological chemistry.

[11]  K. Kaplan,et al.  The binding of thrombin by fibrin. , 1979, The Journal of biological chemistry.

[12]  N. L. Gould,et al.  Thrombin Receptors of Human Platelets: Thrombin Binding and Antithrombin Properties of Glycoprotein I , 1979, British journal of haematology.

[13]  S. A. Silverberg.  Proteolysis of prothrombin by thrombin. Determination of kinetic parameters, and demonstration and characterization of an unusual inhibition by Ca2+ ions. , 1979, The Journal of biological chemistry.

[14]  K. Mann,et al.  Comparison of the inhibition of thrombin by three plasma protease inhibitors. , 1978, Biochemistry.

[15]  G. Jamieson,et al.  Platelet glycocalicin. Interaction with thrombin and role as thrombin receptor of the platelet surface. , 1978, The Journal of biological chemistry.

[16]  J. Jesty.  The inhibition of activated bovine coagulation factors X and VII by antithrombin III. , 1978, Archives of biochemistry and biophysics.

[17]  J. Fenton,et al.  Human thrombins. Production, evaluation, and properties of alpha-thrombin. , 1977, The Journal of biological chemistry.

[18]  P. Agin,et al.  Platelet plasma membrane glycoproteins. Identification of a proteolytic substrate for thrombin. , 1977, Biochemical and biophysical research communications.

[19]  P. Majerus,et al.  Evidence for a single class of thrombin-binding sites of human platelets. , 1976, Biochemistry.

[20]  K. Kurachi,et al.  Characterization of human, bovine, and horse antithrombin III. , 1976, Biochemistry.

[21]  L. Andersson,et al.  Purification of antithrombin III by affinity chromatography , 1974 .

[22]  J. van der Meer,et al.  Antithrombin-III deficiency in a Dutch family , 1973 .

[23]  P. R. Bevington,et al.  Data Reduction and Error Analysis for the Physical Sciences , 1969 .

[24]  O. Egeberg.  Inherited Antithrombin Deficiency Causing Thrombophilia , 1965, Thrombosis and Haemostasis.

[25]  M. Karnovsky,et al.  Inhibition of vascular smooth muscle cell growth by endothelial cell-derived heparin. Possible role of a platelet endoglycosidase. , 1982, The Journal of biological chemistry.

[26]  R. Grant,et al.  Correlation between fibrinogen binding to human platelets and platelet aggregability. , 1980, Blood.

[27]  A. Fersht.  Enzyme structure and mechanism , 1977 .